Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Self-report versus performance measure in gauging level of function with multiple sclerosis.
Propentofylline treatment on open field behavior in rats with focal ethidium bromide-induced demyelination in the ventral surface of the brainstem.
Effects of pooled human immunoglobulins in an animal model of neuromyelitis optica with chronic application of autoantibodies to aquaporin 4.
Clinically Significant Fatigue: Prevalence and Associated Factors in an International Sample of Adults with Multiple Sclerosis Recruited via the Internet.
Methionyl-tRNA Formyltransferase (MTFMT) Deficiency Mimicking Acquired Demyelinating Disease.
Blood B Cell and Regulatory Subset Content in Multiple Sclerosis Patients.
Medication possession ratio: implications of using fixed and variable observation periods in assessing adherence with disease-modifying drugs in patients with multiple sclerosis.
Can somatosensory evoked potentials predict disease course in early multiple sclerosis patients?
Culturing microglia from the neonatal and adult central nervous system.
Electrolyte imbalance triggering relapse of inflammatory neuropathy.
Teriflunomide for the treatment of relapsing multiple sclerosis: a review of clinical data.
MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies.
Factors associated with unemployment among persons with multiple sclerosis.
Functional magnetic resonance imaging movers and shakers: Does subject-movement cause sampling bias?
Mouse Models of Multiple Sclerosis: Experimental Autoimmune Encephalomyelitis and Theiler's Virus-Induced Demyelinating Disease.
Reliability of Intra-Retinal Layer Thickness Estimates.
Social Cognitive Correlates of Physical Activity in African-Americans with Multiple Sclerosis.
Overexpression of CD44 in Neural Precursor Cells Improves Trans- Endothelial Migration and Facilitates Their Invasion of Perivascular Tissues In Vivo.
New and Emerging Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: What is New and What is to Come.
Clinicopathological features in anterior visual pathway in neuromyelitis optica.
Feasibility of Cell Therapy in Multiple Sclerosis: A Systematic Review of 83 Studies.
Discovery of Clinical Candidate GSK1842799 As a Selective S1P1 Receptor Agonist (Prodrug) for Multiple Sclerosis.
Cognitive and brain reserve for mind-body therapeutic approaches in multiple sclerosis: A review.
Damping of monocular pendular nystagmus with vibration in a patient with multiple sclerosis.
Complement C1q-C3 associated synaptic changes in multiple sclerosis hippocampus.

Pages